Recall events
/
Event 88862
Event summary
Timeline bucket October 12, 2021
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
130 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 130
Estradiol Valerate 20 mg/mL in Ethyl Oleate Inj. 20 mg/mL Injection in vials, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0097-2022
Recall number D-0097-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 335 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 04122021:51 BUD: 10/09/2021; 04232021:94 BUD: 10/20/2021; 05032021:52 BUD: 10/30/2021; 05242021:73 BUD: 11/20/2021; 05172021:47 BUD: 11/13/2021; 06302021:93 BUD: 12/27/2021; 06222021:98 BUD: 12/19/2021; 06072021:83 BUD: 12/04/2021; 07152021:86 BUD: 01/11/2022; 07222021:52 BUD: 01/18/2022; 08062021:11 BUD: 02/02/2022; 08192021:73 BUD: 02/15/2022; 08312021:22 BUD: 02/27/2022; 09162021:58 03/15/2022; 09082021:15 BUD: 03/07/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13079]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 130
(WELL'S LIPO-LEAN)INOSITOL/CHOLINE/B-COMP+LEUCINE+CARN+ CHROM+LIDO 25MG/25MG/1.5MG/25MG/25MCG/10MG INJECTABLE in vials, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0098-2022
Recall number D-0098-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08062021:30 BUD: 10/31/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12412]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 130
ALPROSTADIL 22.5MCG/ML 22.5MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0099-2022
Recall number D-0099-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08022021:14 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13163]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 130
ALPROSTADIL 22MCG/ML 22MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0100-2022
Recall number D-0100-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06082021:61 BUD: 10/06/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12879]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 130
ALPROSTADIL 25MCG/ML 25MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0101-2022
Recall number D-0101-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 04232021:91 BUD: 10/20/2021; 08022021:76 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12319]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 130
ALPROSTADIL 30MCG/ML INJ 30MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0102-2022
Recall number D-0102-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06142021:35 BUD: 10/23/2021; 07282021:49 BUD: 01/24/2022; 08302021:48 BUD: 02/26/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12897]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 130
ALPROSTADIL 32MCG/ML 32MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0103-2022
Recall number D-0103-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08262021:68 BUD: 12/24/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12899]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 130
ALPROSTADIL 40MCG/ML INJ 40MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0104-2022
Recall number D-0104-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06242021:37 BUD: 10/22/2021; 08132021:74 BUD: 12/11/2021; 07132021:94 BUD:10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12277]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 130
ALPROSTADIL 45MCG/ML 45MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0105-2022
Recall number D-0105-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06112021:61 BUD: 10/09/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12434]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 130
B COMPLEX INJ CMP-NO B12, NO LIDOCAINE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0106-2022
Recall number D-0106-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07192021:91 BUD: 10/17/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12408]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 130
BI-MIX PAPAVERINE 40/PHENTOLAMINE 2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0107-2022
Recall number D-0107-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08182021:00 BUD: 12/16/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13160]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 130
BLUE TREE LIPO EXTREME (/W METHYLCOBALAMIN) INJECTION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0108-2022
Recall number D-0108-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 8 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09172021:87 BUD: 12/16/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12504]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 130
CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0109-2022
Recall number D-0109-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 15 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05242021:73 BUD: 08/22/2021; 08032021:26 BUD: 11/01/2021; 06022021:49 BUD: 08/31/2021; 08122021:97 BUD: 11/10/2021;
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12290]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 130
ESTRADIOL VALERATE 10MG/ML IN ETHYL OLEATE 10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0110-2022
Recall number D-0110-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06232021:55 BUD: 12/20/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12883]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 130
ESTRADIOL VALERATE 30MG/ML INJ #1 IN ETHYL OLEATE OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0111-2022
Recall number D-0111-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 04262021:43 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12423]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 130
ESTRADIOL VALERATE 40MG/ML IN ETHYL OLEATE INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0112-2022
Recall number D-0112-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 11 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09082021:11 BUD: 03/07/2022; 07022021:66 BUD: 12/29/2021; 05202021:46 BUD: 11/16/2021; 08192021:24 BUD: 02/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13090]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 130
ESTRADIOL VALERATE 50MG/ML IN ETHYL OLEATE INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0113-2022
Recall number D-0113-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 15 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09162021:29 BUD: 03/15/2022; 09132021:31 BUD: 03/12/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12951]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 130
ESTRADIOL VALERATE 50MG/ML INJ #2 INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0114-2022
Recall number D-0114-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09162021:22 BUD: 03/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13083]
FDA event record
· Exact recall-number query on openFDA
drug · product 19 of 130
ESTRADIOL VALERATE 5MG/ML IN ETHYL OLEATE 5MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0115-2022
Recall number D-0115-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 7 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07232021:10 BUD: 01/19/2022; 04162021:56 BUD: 10/13/2021; 08172021:62 BUD: 02/13/2022; 05272021:21 BUD: 11/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12976]
FDA event record
· Exact recall-number query on openFDA
drug · product 20 of 130
GOAL-GLUTAMINE 75MG/ORNITHINE 75MG/ARGININE 150MG/LYSINE 150MG+LIDOCAINE 10MG/ML 75MG/75MG/150MG/150MG/10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0116-2022
Recall number D-0116-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05062021:44 BUD: 11/02/2021; 08192021:87 BUD: 02/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12991]
FDA event record
· Exact recall-number query on openFDA
drug · product 21 of 130
HYDROXOCOBALAMIN 1,000MCG/ML INJ VIAL 1,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0117-2022
Recall number D-0117-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09102021:19 BUD: 11/09/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13065]
FDA event record
· Exact recall-number query on openFDA
drug · product 22 of 130
HYDROXOCOBALAMIN 5,000MCG/ML INJ 5,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0118-2022
Recall number D-0118-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08242021:51 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12410]
FDA event record
· Exact recall-number query on openFDA
drug · product 23 of 130
IC B COMPLEX INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0119-2022
Recall number D-0119-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09152021:12 BUD: 12/14/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12636]
FDA event record
· Exact recall-number query on openFDA
drug · product 24 of 130
IVME HCG VITAMIN B INJ (CONTAINS NO HCG) INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0120-2022
Recall number D-0120-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 122 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09092021:04 BUD: 12/09/2021; 07262021:55 BUD: 10/24/2021;
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12961]
FDA event record
· Exact recall-number query on openFDA
drug · product 25 of 130
IVME SUPER B INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0121-2022
Recall number D-0121-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 99 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07262021:54 BUD: 10/24/2021; 07262021:04 BUD: 10/24/2021; 09092021:07 BUD: 12/09/2021; 09092021:97 BUD: 12/09/2021; 09102021:10 BUD: 12/09/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13172]
FDA event record
· Exact recall-number query on openFDA
drug · product 26 of 130
L-CARNITINE 250MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0122-2022
Recall number D-0122-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08172021:31 BUD: 11/15/2021; 07152021:16 BUD: 10/13/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12978]
FDA event record
· Exact recall-number query on openFDA
drug · product 27 of 130
LEUCINE 10MG/ ISOLEUCINE 15MG/ VALINE 40MG/ML (BCAA) INJ 10MG/15MG/40MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0123-2022
Recall number D-0123-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05072021:81 BUD: 11/03/2021; 08122021:08 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12655]
FDA event record
· Exact recall-number query on openFDA
drug · product 28 of 130
MEDROXYPROGESTERONE ACET 150MG/ML SUSP (PF) 150MG/ML SUSPENSION, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0124-2022
Recall number D-0124-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 696 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07222021:40 BUD: 10/20/2021; 03302021:60 BUD: 10/26/2021; 04122021:29 BUD: 11/08/2021; 08172021:38 BUD: 11/15/2021; 07072021:60 BUD: 10/05/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13086]
FDA event record
· Exact recall-number query on openFDA
drug · product 29 of 130
METHYLCOBALAMIN 1MG/ML (1000MCG/ML) INJ 1MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0125-2022
Recall number D-0125-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 324 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07292021:79 BUD: 10/27/2021; 09072021:33 BUD: 12/07/2021; 09072021:32 BUD: 12/07/2021; 08312021:30 BUD: 11/29/2021; 07222021:66 BUD: 10/20/2021; 08242021:10 BUD: 11/22/2021; 07262021:12 BUD: 10/24/2021; 08182021:08 BUD: 11/16/2021; 09072021:31 BUD: 12/07/2021; 09092021:32 BUD: 12/08/2021; 09212021:12 BUD: 12/20/2021; 09212021:88 BUD: 12/20/2021.
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13089]
FDA event record
· Exact recall-number query on openFDA
drug · product 30 of 130
METHYLCOBALAMIN 5MG/ML (5000MCG/ML) INJ 5MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0126-2022
Recall number D-0126-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07162021:70 BUD: 10/14/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13176]
FDA event record
· Exact recall-number query on openFDA
drug · product 31 of 130
MIC 20/40/50 /B COMPLEX +CHROM/CARN 25/25MG/ML 20/40/50/25/25MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0127-2022
Recall number D-0127-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08172021:52 BUD: 02/13/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12989]
FDA event record
· Exact recall-number query on openFDA
drug · product 32 of 130
MIC 20/40/50 /B COMPLEX +CHROM/CARN 25/25MG/ML+LIDO 20/40/50/25/25MG/ML+LIDO INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0128-2022
Recall number D-0128-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07292021:73 BUD: 10/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12432]
FDA event record
· Exact recall-number query on openFDA
drug · product 33 of 130
MIC B COMPLEX INJ-MILES FORMULATION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0129-2022
Recall number D-0129-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08112021:46 BUD: 11/09/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12892]
FDA event record
· Exact recall-number query on openFDA
drug · product 34 of 130
MIC B COMPLEX W CHROMIUM/ METHYLCOB (BOYDEN) INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0130-2022
Recall number D-0130-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09022021:50 BUD: 12/01/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12292]
FDA event record
· Exact recall-number query on openFDA
drug · product 35 of 130
MIC B COMPLEX WITH HYDROXOCOBALAMIN 5MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0131-2022
Recall number D-0131-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07152021:91 BUD: 10/13/2021; 08202021:06 BUD: 11/18/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12309]
FDA event record
· Exact recall-number query on openFDA
drug · product 36 of 130
MIC B12 25/50/50/0.5MG/ML L-CARNITINE 250MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0132-2022
Recall number D-0132-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07272021:62 BUD: 10/25/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12878]
FDA event record
· Exact recall-number query on openFDA
drug · product 37 of 130
MIC B12 25/50/50/1+B6 100 MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0133-2022
Recall number D-0133-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08112021:23 BUD: 11/09/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12950]
FDA event record
· Exact recall-number query on openFDA
drug · product 38 of 130
PROGESTERONE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0134-2022
Recall number D-0134-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07192021:31 BUD: 10/17/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12640]
FDA event record
· Exact recall-number query on openFDA
drug · product 39 of 130
QUAD-MIX PAPAV 20/PHENTOL 2/PGE-1 25/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0135-2022
Recall number D-0135-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08032021:56 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12974]
FDA event record
· Exact recall-number query on openFDA
drug · product 40 of 130
QUAD-MIX PAPAV 30/PHENTOL 1/PGE-1 10/ATROPINE 0.15 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0136-2022
Recall number D-0136-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07072021:20 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12502]
FDA event record
· Exact recall-number query on openFDA
drug · product 41 of 130
QUAD-MIX PAPAV 30/PHENTOL 1/PGE-1 20/ATROPINE 0.1 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0137-2022
Recall number D-0137-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08052021:10 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12517]
FDA event record
· Exact recall-number query on openFDA
drug · product 42 of 130
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 20/ATROPINE 0.2 INJ *C5* INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0138-2022
Recall number D-0138-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06292021:27 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12643]
FDA event record
· Exact recall-number query on openFDA
drug · product 43 of 130
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 200/ATROPINE 0.02 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0139-2022
Recall number D-0139-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 0802021:26 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12421]
FDA event record
· Exact recall-number query on openFDA
drug · product 44 of 130
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 30/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0140-2022
Recall number D-0140-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08182021:31 BUD: 02/08/2022; 08262021:69 BUD: 02/08/2022; 08052021:40 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12637]
FDA event record
· Exact recall-number query on openFDA
drug · product 45 of 130
QUAD-MIX PAPAV 30/PHENTOL 3/PGE-1 100/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0141-2022
Recall number D-0141-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07162021:24 BUD: 11/13/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12520]
FDA event record
· Exact recall-number query on openFDA
drug · product 46 of 130
QUAD-MIX PAPAV 30/PHENTOL 4/PGE-1 40/ATROPINE 0.4 INJ *C6* INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0142-2022
Recall number D-0142-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07192021:52 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13155]
FDA event record
· Exact recall-number query on openFDA
drug · product 47 of 130
SERMORELIN ACETATE 15MG/IPAMORELIN 15MG - LYOPHILIZED 15MG/15MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0143-2022
Recall number D-0143-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07062021:98 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12895]
FDA event record
· Exact recall-number query on openFDA
drug · product 48 of 130
SERMORELIN ACETATE 6MG/IPAMORELIN 6MG - LYOPHILIZED 6MG/6MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0144-2022
Recall number D-0144-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 11 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06022021:03 BUD: 11/29/2021; 08102021:27 BUD: 11/30/2021; 05212021:84 BUD: 11/17/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13058]
FDA event record
· Exact recall-number query on openFDA
drug · product 49 of 130
SERMORELIN ACETATE 9MG/IPAMORELIN 9MG - LYOPHILIZED 9MG/9MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0145-2022
Recall number D-0145-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08102021:22 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12963]
FDA event record
· Exact recall-number query on openFDA
drug · product 50 of 130
TRIMTROPIC - MIC B COMPLEX/CHROM/CARN 20MG/40MG/50MG/5MG/33MG/2MG/1MG/25MCG/25MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0146-2022
Recall number D-0146-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08062021:92 BUD: 02/02/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12291]
FDA event record
· Exact recall-number query on openFDA
drug · product 51 of 130
TRI-TEST 200 (CY50%-EN37.5%-PR12.5%) INJ #1 200MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0147-2022
Recall number D-0147-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007302021:37 BUD: 01/26/2022; T1008242021:04 BUD: 02/20/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12873]
FDA event record
· Exact recall-number query on openFDA
drug · product 52 of 130
ULTRA-TEST (CYP 80%/PROP 20%) 200MG/ML INJ #1 200MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0148-2022
Recall number D-0148-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 23 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008032021:86 BUD: 01/30/2022; T1004192021:25 BUD: 10/16/2021; T1005252021:33 BUD: 11/21/2021; T1009082021:96 BUD: 03/07/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13148]
FDA event record
· Exact recall-number query on openFDA
drug · product 53 of 130
VITAMIN D3 100,000 IU/ML INJECTABLE 100,000IU/ML, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0149-2022
Recall number D-0149-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 23 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05272021:20 BUD: 11/23/2021; 06142021:34 BUD: 12/11/2021; 08052021:18 BUD: 01/05/2022; 08192021:43 BUD: 01/05/2022; 03302021:15 BUD: 08/12/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12305]
FDA event record
· Exact recall-number query on openFDA
drug · product 54 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.25MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0150-2022
Recall number D-0150-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1006032021:64 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12425]
FDA event record
· Exact recall-number query on openFDA
drug · product 55 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0151-2022
Recall number D-0151-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 23 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07292021:54 BUD: 01/25/2022; T1006302021:96 BUD: 12/27/2021; T1008092021:60 BUD: 02/05/2022; T1009222021:51 BUD: 03/21/2022; T1006082021:79 BUD: 12/05/2021; T1008302021:82 BUD: 02/26/2022;
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12492]
FDA event record
· Exact recall-number query on openFDA
drug · product 56 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0152-2022
Recall number D-0152-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1005192021:31 BUD: 11/15/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12419]
FDA event record
· Exact recall-number query on openFDA
drug · product 57 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0153-2022
Recall number D-0153-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007012021:96 BUD: 12/28/2021; T1008192021:04 BUD: 02/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13069]
FDA event record
· Exact recall-number query on openFDA
drug · product 58 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1MG/ML #2 INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0154-2022
Recall number D-0154-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008252021:29 BUD: 02/21/2022; T1006042021:51 BUD: 12/01/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13168]
FDA event record
· Exact recall-number query on openFDA
drug · product 59 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0155-2022
Recall number D-0155-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 50 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008192021:69 BUD: 02/15/2022; T1006142021:66 BUD: 12/11/2021; T1009092021:76 BUD: 03/08/2022; T1005142021:82 BUD: 11/10/2021; T1009212021:33 BUD: 03/20/2022; T1006012021:01 BUD: 11/28/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13082]
FDA event record
· Exact recall-number query on openFDA
drug · product 60 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 0.75MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0156-2022
Recall number D-0156-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008312021:33 BUD: 02/27/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12289]
FDA event record
· Exact recall-number query on openFDA
drug · product 61 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1.5MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0157-2022
Recall number D-0157-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1009092021:66 BUD: 03/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12307]
FDA event record
· Exact recall-number query on openFDA
drug · product 62 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1.5MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0158-2022
Recall number D-0158-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1009092021:19 BUD: 03/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12316]
FDA event record
· Exact recall-number query on openFDA
drug · product 63 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0159-2022
Recall number D-0159-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 13 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007072021:98 BUD: 01/03/2022; T1005252021:31 BUD: 11/21/2021; T1009222021:60 BUD: 03/21/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12876]
FDA event record
· Exact recall-number query on openFDA
drug · product 64 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0160-2022
Recall number D-0160-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1009132021:38 BUD: 03/12/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12972]
FDA event record
· Exact recall-number query on openFDA
drug · product 65 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0161-2022
Recall number D-0161-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 19 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1005172021:27 BUD: 11/13/2021; T1007222021:42 BUD: 01/18/2022; T1009162021:45 BUD: 03/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12896]
FDA event record
· Exact recall-number query on openFDA
drug · product 66 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0162-2022
Recall number D-0162-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1009222021:34 BUD: 03/21/2022; T1008022021:71 BUD: 01/29/2022; T1006072021:73 BUD: 12/04/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12286]
FDA event record
· Exact recall-number query on openFDA
drug · product 67 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0163-2022
Recall number D-0163-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1006032021:45 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12516]
FDA event record
· Exact recall-number query on openFDA
drug · product 68 of 130
TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0164-2022
Recall number D-0164-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007142021:50 BUD: 01/10/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12531]
FDA event record
· Exact recall-number query on openFDA
drug · product 69 of 130
TEST CYPIONATE 200MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0165-2022
Recall number D-0165-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 21 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1006042021:53 BUD: 12/01/2021; T1008192021:83 BUD: 02/15/2022; T1005212021:52 BUD: 11/17/2021; T1009072021:35 BUD: 03/06/2022; T1007132021:61 BUD: 01/09/2022; T1009142021:95 BUD: 03/13/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12527]
FDA event record
· Exact recall-number query on openFDA
drug · product 70 of 130
TEST CYPIONATE 200MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0166-2022
Recall number D-0166-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008312021:02 BUD: 02/27/2022; T1007142021:62 BUD: 01/10/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12986]
FDA event record
· Exact recall-number query on openFDA
drug · product 71 of 130
TEST CYPIONATE 200MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0167-2022
Recall number D-0167-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007222021:38 BUD: 01/18/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12532]
FDA event record
· Exact recall-number query on openFDA
drug · product 72 of 130
TESTOSTERONE BI-BLEND 100/100MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0168-2022
Recall number D-0168-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T7.803162021:08 BUD: 09/12/2021; TBB07142021:68 BUD: 01/10/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12658]
FDA event record
· Exact recall-number query on openFDA
drug · product 73 of 130
TESTOSTERONE CYPIONATE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0169-2022
Recall number D-0169-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 168 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T0204272021:49 BUD: 10/24/2021; T0206142021:55 BUD: 12/11/2021; T0209082021:74 BUD: 03/07/2022; T0506212021:52 BUD: 12/18/2021; T0207082021:41 BUD: 01/04/2022; T0208112021:07 BUD: 02/07/2022; T0206012021:26 BUD: 11/28/2021; T0507122021:00 BUD: 01/08/2022; T0505112021:58 BUD: 11/07/2021; T0205182021:56 BUD: 11/14/2021; T0506102021:88 BUD: 12/07/2021; T0508182021:56 BUD: 02/14/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12304]
FDA event record
· Exact recall-number query on openFDA
drug · product 74 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.25MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0170-2022
Recall number D-0170-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1006092021:18 BUD: 12/06/2021; T1009022021:89 BUD: 03/01/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12283]
FDA event record
· Exact recall-number query on openFDA
drug · product 75 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0171-2022
Recall number D-0171-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 94 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1005122021:40 BUD: 11/08/2021; T1006092021:88 BUD: 12/06/2021; T1008242021:26 BUD: 02/20/2022; T1007192021:94 BUD: 01/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13067]
FDA event record
· Exact recall-number query on openFDA
drug · product 76 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0172-2022
Recall number D-0172-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 9 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1004132021:95 BUD: 10/10/2021; T1006162021:63 BUD: 12/13/2021; T1004282021:19 BUD: 10/25/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12514]
FDA event record
· Exact recall-number query on openFDA
drug · product 77 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0173-2022
Recall number D-0173-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1008032021:52 BUD: 01/30/2022; T1008192021:96 BUD: 02/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13169]
FDA event record
· Exact recall-number query on openFDA
drug · product 78 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.7MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0174-2022
Recall number D-0174-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007202021:25 BUD: 01/16/2022; T1009102021:46 BUD: 03/09/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13084]
FDA event record
· Exact recall-number query on openFDA
drug · product 79 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0175-2022
Recall number D-0175-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1009092021:50 BUD: 03/08/2022; T1006302021:37 BUD: 12/27/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13153]
FDA event record
· Exact recall-number query on openFDA
drug · product 80 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0176-2022
Recall number D-0176-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007132021:95 BUD: 01/09/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12647]
FDA event record
· Exact recall-number query on openFDA
drug · product 81 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0177-2022
Recall number D-0177-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1004202021:52 BUD: 10/17/2021; T1005042021:24 BUD: 10/31/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12650]
FDA event record
· Exact recall-number query on openFDA
drug · product 82 of 130
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0178-2022
Recall number D-0178-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 334 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1006042021:60 BUD: 12/01/2021; T1008302021:63 BUD: 02/26/2022; T1005122021:36 BUD: 11/08/2021; T1007142021:23 BUD: 01/10/2022; T1008192021:94 BUD: 02/15/2022; 04202021:80 BUD: 10/17/2021; T1007012021:31 BUD: 12/28/2021; T1009092021:97 BUD: 03/08/2022; T1004092021:79 BUD: 10/06/2021; T1005242021:08 BUD: 11/20/2021; T1008092021:82 BUD: 02/05/2022; T1005042021:92 BUD: 10/31/2021; T1007262021:03 BUD: 01/22/2022; T1006172021:47 BUD: 12/14/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12295]
FDA event record
· Exact recall-number query on openFDA
drug · product 83 of 130
TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0179-2022
Recall number D-0179-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1229 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007302021:72 BUD: 01/26/2022; T1005182021:09 BUD: 11/15/2021; T1008112021:73 BUD: 02/07/2022; T1004092021:40 BUD: 10/09/2021; T1006182021:37 BUD: 12/15/2021; T1005242021:71 BUD: 11/20/2021; T1006072021:06 BUD: 12/04/2021; T0606222021:35 BUD: 12/19/2021; T0605112021:23 BUD:11/07/2021 ; T0608162021:19 BUD: 02/12/2022; T1009132021:25 BUD: 03/12/2022; T1004272021:41 BUD: 10/24/2021; T0604152021:26 BUD: 10/12/2021; T1006302021:53 BUD: 12/27/2021; T1008022021:01 BUD: 01/29/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1008042021:66 BUD: 01/31/2022; T1007062021:95 BUD: 01/02/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1006142021:21 BUD: 12/11/2021; T1008042021:66 BUD: 01/31/2022; T1005102021:94 BUD: 11/06/2021; T1007282021:89 BUD: 01/24/2022; T1009222021:75 BUD: 03/21/2022; T1005052021:79 BUD: 11/01/2021; T1008192021:65 BUD: 02/15/2022; T1007132021:14 BUD: 01/09/2022; T1008162021:35 BUD: 02/12/2022; T0607282021:28 BUD: 01/24/2022; T1006022021:06 BUD: 11/29/2021; T1006222021:31 BUD: 12/19/2021; T1004292021:70 BUD: 10/26/2021; T1007212021:82 BUD: 01/17/2022; T1006282021:88 BUD: 12/25/2021; T1004222021:18 BUD: 10/19/2021; T1009082021:11 BUD: 03/07/2022; T1007082021:50 BUD: 01/04/2022; T1009212021:76 BUD: 03/20/2022; T1008312021:01 BUD: 02/27/2022; T0507062021:21 BUD: 01/02/2022; T1004152021:11 BUD: 10/12/2021; T1004192021:50 BUD: 10/16/2021; T1005132021:31 BUD: 11/09/2021; T1008252021:57 BUD: 02/21/2022; T1009152021:06 BUD: 03/14/2022; T1007232021:57 BUD: 01/19/2022; T1006162021:17 BUD: 12/13/2021; T1007122021:16 BUD: 01/08/2022; T1006102021:50 BUD: 12/07/2021; T1005282021:72 BUD: 11/24/2021; T0209082021:89 BUD: 03/08/2022; T0106092021:28 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0604152021:26 BUD: 10/12/2021; T0106092021:53 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0209092021:89 BUD: 03/08/2022; T0109032021:43 BUD: 11/07/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12282]
FDA event record
· Exact recall-number query on openFDA
drug · product 84 of 130
TESTOSTERONE CYPIONATE 200MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0180-2022
Recall number D-0180-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 43 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T1007082021:20 BUD: 01/04/2022; T0907262021:21 BUD: 01/04/2022; T0506142021:81 BUD: 12/11/2021; T104142021:49 BUD: 10/11/2021; T1006022021:96 BUD: 11/29/2021; T0507152021:79 BUD: 01/11/2022; T1009082021:42 BUD: 03/07/2022; T0508172021:37 BUD: 02/13/2022; T0505112021:57 BUD: 10/11/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12635]
FDA event record
· Exact recall-number query on openFDA
drug · product 85 of 130
TESTOSTERONE CYPIONATE 20MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0181-2022
Recall number D-0181-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 7 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T0507152021:64 BUD: 01/11/2022; T0507232021:35 BUD: 01/19/2022; T0507292021:15 BUD: 01/25/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13173]
FDA event record
· Exact recall-number query on openFDA
drug · product 86 of 130
TESTOSTERONE CYPIONATE 25MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0182-2022
Recall number D-0182-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 16 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T0508192021:06 BUD: 02/15/2022; T0507022021:91 BUD: 12/29/2021; T0507192021:13 BUD: 01/15/2022; T0504262021:71 BUD: 10/23/2021; T0509172021:03 BUD: 03/16/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12508]
FDA event record
· Exact recall-number query on openFDA
drug · product 87 of 130
TESTOSTERONE CYPIONATE 30MG/ML #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0183-2022
Recall number D-0183-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T0504202021:26 BUD: 10/17/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12512]
FDA event record
· Exact recall-number query on openFDA
drug · product 88 of 130
TESTOSTERONE CYPIONATE 50MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0184-2022
Recall number D-0184-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 40 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: T0207282021:32 BUD: 11/20/2021; T0508162021:62 BUD: 02/12/2022; T0505242021:00 BUD: 11/20/2021; T0207232021:23 BUD: 11/20/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12413]
FDA event record
· Exact recall-number query on openFDA
drug · product 89 of 130
TRI-MIX PAPAV 23.3MG/PHENTOL 1MG/PGE-1 12MCG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0185-2022
Recall number D-0185-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07092021:15 BUD: 10/23/2021; 08182021:65 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12524]
FDA event record
· Exact recall-number query on openFDA
drug · product 90 of 130
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.25/PGE-1 6 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0186-2022
Recall number D-0186-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 24 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot:08192021:49 BUD: 02/08/2022; 08102021:33 BUD: 11/30/2021; 06302021:75 BUD: 10/23/2021; 09032021:05 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13088]
FDA event record
· Exact recall-number query on openFDA
drug · product 91 of 130
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.5/PGE-1 5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0187-2022
Recall number D-0187-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07292021:21 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12317]
FDA event record
· Exact recall-number query on openFDA
drug · product 92 of 130
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 1/PGE-1 10 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0188-2022
Recall number D-0188-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09082021:40 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12435]
FDA event record
· Exact recall-number query on openFDA
drug · product 93 of 130
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 2/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0189-2022
Recall number D-0189-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 09132021:55 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12436]
FDA event record
· Exact recall-number query on openFDA
drug · product 94 of 130
TRI-MIX PAPAVERINE 17.65/PHENTOLAMINE 0.59/PGE-1 5.9 INJ **T 101** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0190-2022
Recall number D-0190-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07262021:32 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12310]
FDA event record
· Exact recall-number query on openFDA
drug · product 95 of 130
TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 5.88/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0191-2022
Recall number D-0191-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08062021:45 BUD: 11/30/2021; 07132021:75 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13149]
FDA event record
· Exact recall-number query on openFDA
drug · product 96 of 130
TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 6/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0192-2022
Recall number D-0192-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08062021:09 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12496]
FDA event record
· Exact recall-number query on openFDA
drug · product 97 of 130
TRI-MIX PAPAVERINE 20/PHENTOLAMINE 1/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0193-2022
Recall number D-0193-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07282021:66 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12311]
FDA event record
· Exact recall-number query on openFDA
drug · product 98 of 130
TRI-MIX PAPAVERINE 23.3/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0194-2022
Recall number D-0194-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08102021:71 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13161]
FDA event record
· Exact recall-number query on openFDA
drug · product 99 of 130
TRI-MIX PAPAVERINE 25/PHENTOLAMINE 3/PGE-1 80 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
D-0195-2022
Recall number D-0195-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08042021:05 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12529]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0196-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08312021:13 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12430]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0197-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08192021:32 BUD: 02/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12956]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0198-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06162021:93 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12288]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0199-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06252021:39 BUD: 10/23/2021; 08132021:31 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13085]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0200-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07142021:10 BUD: 10/23/2021; 08162021:23 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12882]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0201-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06252021:22 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13070]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0202-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08092021:52 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13159]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0203-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07162021:14 BUD: 11/30/2021; 09142021:63 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12954]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0204-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 13 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07092021:34 BUD: 10/23/2021; 08302021:33 BUD: 02/08/2022; 08162021:08 BUD: 02/08/2022; 08262021:31 BUD: 02/08/2022; 09152021:63 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12947]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0205-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 30 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07222021:11 BUD: 11/30/2021; 08172021:72 BUD: 02/08/2022; 06282021:84 BUD: 10/23/2021; 07132021:93 BUD: 10/23/2021; 09102021:43 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13174]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0206-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 22 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07142021:91 BUD: 10/23/2021; 08122021:46 BUD: 02/08/2022; 07092021:88 BUD: 10/23/2021; 08022021:45 BUD: 11/30/2021; 09082021:46 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12985]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0207-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07232021:18 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13080]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0208-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06252021:69 BUD: 10/23/2021; 08272021:62 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13175]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0209-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07272021:15 BUD: 11/30/2021; 07122021:11 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12506]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0210-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 08042021:56 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13061]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0211-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 22 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07192021:23 BUD: 01/15/2022; 08032021:21 BUD: 01/30/2022; 04282021:39 BUD: 10/23/2022; 06102021:69 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13071]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0212-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 7 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06252021:81 BUD: 10/23/2021; 09102021:09 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12534]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0213-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 8 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06232021:01 BUD: 10/23/2021; 08132021:58 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12983]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0214-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07082021:16 BUD: 10/23/2021; 08172021:26 BUD: 02/08/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13171]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0215-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07222021:30 BUD: 11/30/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12298]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0216-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06212021:35 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12500]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0217-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06282021:57 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12979]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0218-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05142021:17 BUD: 10/23/2021; 08062021:79 BUD: 02/02/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12312]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0219-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05142021:17 BUD: 10/23/2021; 08062021:79 BUD: 02/02/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12656]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0220-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 13 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06232021:24 BUD: 10/23/2021; 07192021:69 BUD: 01/15/2022; 09132021:87 BUD: 03/12/2022; 07282021:91 BUD: 01/24/2022; 04162021:06 BUD: 10/13/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12894]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0221-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 05192021:49 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12645]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0222-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07062021:22 BUD: 10/23/2021; 08262021:81 BUD: 02/22/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12318]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0223-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 06012021:18 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12493]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0224-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07142021:43 BUD: 10/23/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12300]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0225-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 04222021:98 BUD: 10/19/2021
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12970]
FDA event record
· Exact recall-number query on openFDA
Recall number D-0226-2022
Initiated October 12, 2021
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility
Code information Lot: 07192021:30 BUD: 01/15/2022
Distribution pattern United States including Washington, D.C. and Puerto Rico
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13060]
FDA event record
· Exact recall-number query on openFDA